`

X4 Pharmaceuticals

Biotechnology Research

Specialities :
Rare disease and primary immunodeficiencies
revenue-icon Revenue
1M - 10M
funding-icon Total Funding
$115.0M
size-icon Size
51 - 200

Frequently Asked Questions About X4 Pharmaceuticals

What does X4 pharmaceuticals do?+

We are a commercial-stage clinical biopharmaceutical company driven to improve the lives of people with rare diseases of the immune system and few to no treatment options. We have successfully developed mavorixafor, receiving FDA approval for XOLREMDITM (mavorixafor) in its first indication, and are currently executing our US launch. We are also advancing mavorixafor for additional rare disease patient populations, and expect to initiate a pivotal, global Phase 3 clinical trial in people with certain chronic neutropenic disorders. With a focus on CXCR4 and immune system biology, we continue to leverage our expertise both at our corporate headquarters in Boston,...

What are X4 pharmaceuticals's specialties? +

Rare disease and primary immunodeficiencies

What is X4 pharmaceuticals's industry? +

X4 pharmaceuticals operates in the Biotechnology research industry.

What is X4 pharmaceuticals's revenue? +

X4 pharmaceuticals's revenue is 1m - 10m

What is X4 pharmaceuticals's company size? +

X4 pharmaceuticals has 51 - 200 employees.

The Go-to Sales Technology According to G2

G2 Badges Map
Get Started With Clodura
Sign Up

Sign Up for Free

Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.

Supercharge Your Prospecting

Supercharge Your Prospecting

Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.

Grow Your Business

Grow Your Business

Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.